Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michihiko Kuwano

Showing results (31-40 of 145) with videos related to

Pageof 15
Sort By:
Cancer Research|May 19, 2006
PTEN/Akt signaling through epidermal growth factor receptor is prerequisite for angiogenesis by hepatocellular carcinoma cells that is susceptible to inhibition by gefitinibShu-Ichi Ueda, Yuji Basaki, Masumi Yoshie, et al.
Thyroid : Official Journal of the American Thyroid Association|May 2, 2006
Activation of protein kinase C delta induces growth arrest in NPA thyroid cancer cells through extracellular signal-regulated kinase mitogen-activated protein kinaseKenta Koike, Teruhiko Fujii, Anna M Nakamura, et al.
The Journal of Rheumatology|June 18, 2002
A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosusSatomi Kanemitsu, Kenji Ihara, Ahmed Saifddin, et al.
International Journal of Oncology|November 4, 2009
Thioredoxin2 enhances the damaged DNA binding activity of mtTFA through direct interactionAkihiko Kidani, Hiroto Izumi, Yoichiro Yoshida, et al.
Journal of Cancer Research and Clinical Oncology|November 30, 2002
Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancerHideaki Yahata, Hiroaki Kobayashi, Toshiharu Kamura, et al.
The Journal of Biological Chemistry|April 19, 2003
Identification of domains participating in the substrate specificity and subcellular localization of the multidrug resistance proteins MRP1 and MRP2Toshikazu Konno, Takuya Ebihara, Keiji Hisaeda, et al.
Current Medicinal Chemistry|March 14, 2008
Preclinical and clinical studies of novel breast cancer drugs targeting molecules involved in protein kinase C signaling, the putative metastasis-suppressor gene Cap43 and the Y-box binding protein-1Teruhiko Fujii, Goro Yokoyama, Hiroki Takahashi, et al.
Cancer Research|July 19, 2002
The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancersYasuhiro Tada, Morimasa Wada, Ken-Ichi Taguchi, et al.
Carcinogenesis|June 17, 2003
The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) miceYasushi Mochida, Ken-ichi Taguchi, Shuichi Taniguchi, et al.
Cancer Research|May 19, 2005
HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cellsAkira Hirata, Fumihito Hosoi, Miho Miyagawa, et al.
Pageof 15

Showing results (31-40 of 145) with videos related to

Sort By:
Pageof 15
Cancer Research|May 19, 2006
PTEN/Akt signaling through epidermal growth factor receptor is prerequisite for angiogenesis by hepatocellular carcinoma cells that is susceptible to inhibition by gefitinibShu-Ichi Ueda, Yuji Basaki, Masumi Yoshie, et al.
Thyroid : Official Journal of the American Thyroid Association|May 2, 2006
Activation of protein kinase C delta induces growth arrest in NPA thyroid cancer cells through extracellular signal-regulated kinase mitogen-activated protein kinaseKenta Koike, Teruhiko Fujii, Anna M Nakamura, et al.
The Journal of Rheumatology|June 18, 2002
A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosusSatomi Kanemitsu, Kenji Ihara, Ahmed Saifddin, et al.
International Journal of Oncology|November 4, 2009
Thioredoxin2 enhances the damaged DNA binding activity of mtTFA through direct interactionAkihiko Kidani, Hiroto Izumi, Yoichiro Yoshida, et al.
Journal of Cancer Research and Clinical Oncology|November 30, 2002
Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancerHideaki Yahata, Hiroaki Kobayashi, Toshiharu Kamura, et al.
The Journal of Biological Chemistry|April 19, 2003
Identification of domains participating in the substrate specificity and subcellular localization of the multidrug resistance proteins MRP1 and MRP2Toshikazu Konno, Takuya Ebihara, Keiji Hisaeda, et al.
Current Medicinal Chemistry|March 14, 2008
Preclinical and clinical studies of novel breast cancer drugs targeting molecules involved in protein kinase C signaling, the putative metastasis-suppressor gene Cap43 and the Y-box binding protein-1Teruhiko Fujii, Goro Yokoyama, Hiroki Takahashi, et al.
Cancer Research|July 19, 2002
The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancersYasuhiro Tada, Morimasa Wada, Ken-Ichi Taguchi, et al.
Carcinogenesis|June 17, 2003
The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) miceYasushi Mochida, Ken-ichi Taguchi, Shuichi Taniguchi, et al.
Cancer Research|May 19, 2005
HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cellsAkira Hirata, Fumihito Hosoi, Miho Miyagawa, et al.
Pageof 15